This inventor holds 1 USPTO granted patent. Top assignee: Txinno Bioscience Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chan Sun Park and His Patent Work.
Introduction
Chan Sun Park is an inventor associated with Gyeonggi-Do, South Korea. His listed patent work concerns a naphthyridinone derivative and its potential use in inhibiting ectonucleotide pyrophosphatase-phosphodiesterase.
Latest Patents
Park is listed on 1 patent: “Novel Naphthyridinone Derivative Having Inhibitory Activity Against Ectonucleotide Pyrophosphatase-Phosphodiesterase and Use Thereof.” The patent describes a chemical derivative with inhibitory activity against the specified enzyme family.
Career Highlights
The available information associates Park with Txinno Bioscience Inc. His listed patent reflects work in medicinal chemistry and the development of compounds with potential biological activity.
Collaborations
Park’s listed coworkers include Seo Jung Han and Sung Joon Kim. They are associated with the patent work on the naphthyridinone derivative.
Conclusion
Chan Sun Park’s recorded invention connects his work at Txinno Bioscience Inc. with research into enzyme-inhibiting compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile